FY 2001 user fee rates
Executive Summary
Drug applications requiring clinical data will cost $309,647, an 8.4% increase from $285,740 in FY 2000. Applications not requiring clinical data, and applications for supplements requiring clinical data, will cost half that amount: $154,823, up from $142,870 in FY 2000. FDA projects the receipt of 163.6 fee-paying full-application-equivalent submissions in FY 2001, 10.1 more than FY 2000's 153.5 estimated receipts. The agency incorporates an FY 2000 inflation adjustment of 3.81% into its FY 2001 user fee rate
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth